More recently, a study in Alzheimer's disease provided even more direct evidence by using human iPSC‐derived neural progenitor cells, demonstrating that CHI3L1 suppresses neuronal differentiation and β‐catenin activity in a CRTH2‐dependent manner [51]. This evidence concerns the gene PTGDR2 and early-onset autosomal dominant Alzheimer disease.